Approved for peripheral neuropathic pain in non-diabetic adults SAN MATEO, Calif., May 21 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nasdaq: NGSX ), a biopharmaceutical company focused on developing and commercializing novel pain management therapies ...
- Recent posts
- bPain Management/b Cruise Conference (Conference Alerts - academic b.../b
- What To Expect When I Visit bPain Management/b Clinic For b.../b
- Medical Smartphones: Epocrates bPain/b Resource Center
- Atlanta Outpatient Facility Opens Chronic Pain with Addiction Program - Transworld News
- The gap between pain management – and returning to work ...
- Taking Great Pains to Cope with Pain - CNW Group
- Music May Temper Pain in Preemies - Forbes
- Pain Management during Labor and Delivery
- Cancer Awareness: The Facts About Pain Management | Univesrity ...
- Morris County doctor admits he molested four patients - Newark Star-Ledger
- NeurogesX Receives European Commission Approval for Qutenza(TM) - StreetInsider.com
- Ethical Challenges in Pain Management Post-Surgery -- Rejeh et al ...
- China Aoxing Pharmaceutical Company Acquires a Novel Menstrual Pain ... - Market Wire
- Global Pain Management Set To Drive Transdermal Patches And Gels To $8 ... - Medical News Today
- Pharmaceutical Feature: Global Pain Management Set to Drive ...
- Pain management guidelines suggest opioids for older adults - Daily Reflector
- Walmart pharmacy: Global Pain Management Set To Drive Transdermal ...
- Archimedes Pharma Announces Ground Breaking Phase III Data Showing ... - Medical News Today
- Center for Practical Bioethics sets up $3M pain-care chair - Birmingham Business Journal
- Paradigm Management Services Promotes Thomas Schell to Senior Vice ... - PR Inside